Cloned human neuropeptide Y receptor couples to two different second messenger systems.
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Neuropeptide Y (NPY) is one of the most abundant neuropeptides in the mammalian nervous system and exhibits a diverse range of important physiological activities, including effects on psychomotor activity, food intake, regulation of central endocrine secretion, and potent vasoactive effects on the cardiovascular system. Two major subtypes of NPY receptor (Y1 and Y2) have been defined by pharmacological criteria. We report here the molecular cloning of a cDNA sequence encoding a human NPY receptor and the corrected sequence for a rat homologue. Analysis of this sequence confirms that the receptor is a member of the G protein-coupled receptor superfamily. When expressed in Chinese hamster ovary (CHO) or human embryonic kidney (293) cells, the receptor exhibits the characteristic ligand specificity of a Y1 type of NPY receptor. In the 293 cell line, the receptor is coupled to a pertussis toxin-sensitive G protein that mediates the inhibition of cyclic AMP accumulation. In the CHO cell line, the receptor is coupled not to the inhibition of adenylate cyclase but rather to the elevation of intracellular calcium. These results demonstrate that second messenger coupling of the NPY-Y1 receptor is cell type specific, depending on the specific repertoire of G proteins and effector systems present in any cell type.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Tatemoto, K., Carlquist, M., & Mutt, V. (1982) · Nature · doi:10.1038/296659a0 · Cited by 2,269
Neuropeptide Y distribution in human brain
Adrian, T. E., Allen, J. M., Bloom, S. R., Ghatei, M. A., Rossor, M. N., Roberts, G. W., Crow, T. J., Tatemoto, K., & Polak, J. M. (1983) · Nature · doi:10.1038/306584a0 · Cited by 701
Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides
Wahlestedt, C., Yanaihara, N., & Håkanson, R. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90048-0 · Cited by 631
[Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist.
Fuhlendorff, J., Gether, U., Aakerlund, L., Langeland-Johansen, N., Thøgersen, H., Melberg, S. G., Olsen, U. B., Thastrup, O., & Schwartz, T. W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.182 · Cited by 375
STROSBERG, A. D. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb15778.x · Cited by 241
Eva, C., Keinänen, K., Monyer, H., Seeburg, P., & Sprengel, R. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80377-u · Cited by 237
Heilig, M., & Widerlöv, E. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb01366.x · Cited by 176
Cited by
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, C. C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., & Springer, T. A. (1996) · Nature · doi:10.1038/382829a0 · Cited by 1,953
A receptor subtype involved in neuropeptide-Y-induced food intake
Gerald, C., Walker, M. W., Criscione, L., Gustafson, E. L., Batzl-Hartmann, C., Smith, K. E., Vaysse, P., Durkin, M. M., Laz, T. M., Linemeyer, D. L., et al. (1996) · Nature · doi:10.1038/382168a0 · Cited by 891
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor
Neote, K., DiGregorio, D., Mak, J. Y., Horuk, R., & Schall, T. J. (1993) · Cell · doi:10.1016/0092-8674(93)90118-a · Cited by 763
Simonneaux, V., & Ribelayga, C. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.2 · Cited by 740
“Interestingly, it displays a nonphotic-like effect during the subjective day via presynaptic Y2-R and inhibits photic phase shifting during the subjective night via postsynaptic Y5-R, and maybe Y1-R (see Gribkoff et al., 1998; Yannielli and Harrington, 2001; for reviews).”
MethodInfluentialNakajima, Y., Iwakabe, H., Akazawa, C., Nawa, H., Shigemoto, R., Mizuno, N., & Nakanishi, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50280-0 · Cited by 739
Integration of NPY, AGRP, and Melanocortin Signals in the Hypothalamic Paraventricular Nucleus
Cowley, M. A., Pronchuk, N., Fan, W., Dinulescu, D. M., Colmers, W. F., & Cone, R. D. (1999) · Neuron · doi:10.1016/s0896-6273(00)80829-6 · Cited by 617
The hypothalamus and the control of energy homeostasis
Williams, G., Bing, C., Cai, X. J., Harrold, J. A., King, P. J., & Liu, X. H. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(01)00612-6 · Cited by 578
Y-receptor subtypes—how many more?
Blomqvist, A. G., & Herzog, H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01057-0 · Cited by 529
Self-citationPheochromocytoma: State-of-the-Art and Future Prospects
Bravo, E. L., & Tagle, R. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0013 · Cited by 493
Loetscher, M., Geiser, T., O'Reilly, T., Zwahlen, R., Baggiolini, M., & Moser, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42339-8 · Cited by 445
Regional distribution of Y‐receptor subtype mRNAs in rat brain
Parker, R. M. C., & Herzog, H. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00553.x · Cited by 411
Self-citationWahlestedt, C., & Reis, D. J. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.001521 · Cited by 385
Bard, J. A., Walker, M. W., Branchek, T. A., & Weinshank, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26762 · Cited by 376
Lundell, I., Blomqvist, A. G., Berglund, M. M., Schober, D. A., Johnson, D., Statnick, M. A., Gadski, R. A., Gehlert, D. R., & Larhammar, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29123 · Cited by 318
Thorsell, A., Michalkiewicz, M., Dumont, Y., Quirion, R., Caberlotto, L., Rimondini, R., Mathé, A. A., & Heilig, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220232997 · Cited by 315
Neuropeptide Y: the universal soldier
Pedrazzini, T., Pralong, F., & Grouzmann, E. (2003) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180300029 · Cited by 286
Cloning and Expression of a Novel Neuropeptide Y Receptor
Weinberg, D. H., Sirinathsinghji, D. J. S., Tan, C. P., Shiao, L.-L., Morin, N., Rigby, M. R., Heavens, R. H., Rapoport, D. R., Bayne, M. L., Cascieri, M. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16435 · Cited by 275
Gerald, C., Walker, M. W., Vaysse, P. J.-J., He, C., Branchek, T. A., & Weinshank, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26758 · Cited by 272
Therapeutic potential of neuropeptide Y (NPY) receptor ligands
Brothers, S. P., & Wahlestedt, C. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000100 · Cited by 267
Berglund, M. M., Hipskind, P. A., & Gehlert, D. R. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800301 · Cited by 260
The homeostatic role of neuropeptide Yin immune function and its impact on mood and behaviour
Farzi, A., Reichmann, F., & Holzer, P. (2015) · Acta Physiologica · doi:10.1111/apha.12445 · Cited by 145
“In some cells, NPY can also activate pertussis toxin-insensitive Gq proteins activating protein kinase C (PKC) and extracellular signal-regulated kinase 1/2 (Herzog et al. 1992, Goldberg et al. 1998, Yang et al. 2008, Persaud & Bewick 2014).”
BackgroundNew targets to treat obesity and the metabolic syndrome
Martin, K. A., Mani, M. V., & Mani, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.093 · Cited by 121
Vella, K. R., Ramadoss, P., Lam, F. S., Harris, J. C., Ye, F. D., Same, P. D., O'Neill, N. F., Maratos-Flier, E., & Hollenberg, A. N. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.009 · Cited by 104
Klenke, U., Constantin, S., & Wray, S. (2010) · Endocrinology · doi:10.1210/en.2009-1198 · Cited by 84
Engler, D., Redei, E., & Kola, I. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0376 · Cited by 79
Sarkar, S., & Lechan, R. M. (2003) · Endocrinology · doi:10.1210/en.2002-220675 · Cited by 63
“Because NPY receptors can couple to inhibitory G(i/o) proteins, effectively reducing intracellular concentrations of cAMP (23), we raised the possibility that the increase in NPY during fasting may contribute to inhibition of the hypothalamic-pituitary-thyroid axis by interfering with melanocortin signaling at a postr…”
BackgroundResultNeuropeptide Y: History and Overview
Tatemoto, K. (2004) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-18764-3_1 · Cited by 52
“(Krause et al. 1992; Herzog et al. 1992; Larhammar et al. 1992).”
Background
Metadata
- Authors
- Herzog, H., Hort, Y. J., Ball, H. J., Hayes, G., Shine, J., & Selbie, L. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-07
- Volume
- 89
- Issue
- 13
- Pages
- 5794-5798
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2015301110
- Cited by
- 434
- References
- 13
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.